CanNordic a/s: Financial statements 2013
CVR: 33871902
Source: annual report 2013, Danish Business Authority
01/10/2012 – 30/09/2013
CanNordic a/s (CVR 33871902) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 324,932 and a net result of DKK 89,169. Equity in the 2013 report amounted to DKK 125,053. The solvency ratio was 74.7%.
- Gross Profit
- DKK 324,932
- Profit/Loss
- DKK 89,169
- Equity
- DKK 125,053
- Total Assets
- DKK 167,455
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
CanNordic a/s has published its interim report for the period August 19, 2011 – September 30, 2012.
About CanNordic a/s
CanNordic a/s is a Danish company of the type Aktieselskab based in København Ø, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named GALAXA PHARMA ApS. The management consists of Lone Henriksen. The board consists of Gitte Henriksen, Jens Jørgen Hagelskjær and Lone Henriksen. The company is owned by CS MEDICA a/s. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK -100,395 and a net result of DKK -6,219,720 compared with DKK -4,881,640 the year before. Equity in the 2025 report amounted to DKK 4,298,968.